ArticlePloS one2025
Effects of rumen-protected or unprotected Clostridium butyricum on growth performance, rumen fermentation, immunity and antioxidation in fattening goats.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Goat Bile Acid and Clostridium butyricum Exert a Synergistic Effect in Enhancing the Therapeutic Efficacy Against Diarrhea Induced by Escherichia coli Infection.Probiotics and antimicrobial proteins · 2026Article
- Research progress of Rumen microbes utilizing lignocellulose for high-value chemical production.Biodesign research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Probiotics have been suggested to promote growth and immune performance in animals through long-term feeding. Among probiotics, Clostridium butyricum (C. butyricum) has been shown to have varying effects on the growth of ruminants. However, the impact of rumen-protected C. butyricum on ruminant organisms remains unclear. This study aimed to investigate the effects of rumen-protected and rumen-unprotected C. butyricum on the growth and plasma metabolites of fattening goats after lipopolysaccharide (LPS) challenge. A total of 24 fattening goats, aged 7-8 months, were randomly assigned to one of the following treatments: (1) control (CON); (2) unprotected C. butyricum (CB); and (3) rumen-protected C. butyricum (RPCB). After a 10-week feeding experiment (including two weeks of preparatory experiments), the goats were injected subcutaneously with LPS (1 μg/kg BW). The three treatments did not significantly affect growth performance, digestibility, or antioxidant enzyme activity (P > 0.05). However, the RPCB group showed a greater ability to reduce propionic acid (35.8%) in the rumen (P < 0.01) than did the CB group, thus alleviating the decrease in rumen pH (CB = 5.93, RPCB = 6.13, P < 0.01). Furthermore, the β-oxidation products in the plasma increased in both the CB and RPCB groups (P < 0.01). The difference in the fecal flora between the CB and RPCB groups was limited, but the content of harmful bacteria in the feces of the other two groups decreased compared with that in the CON group (P < 0.01). Unprotected C. butyricum increased the concentration of IgM after LPS injection (P < 0.01). 8-Amino-7-oxononanoate (KAPA) can serve as a biomarker for the effect of C. butyricum on the body. Overall, although rumen-protected C. butyricum could alleviate the decrease in rumen pH, our results suggest that direct feeding of C. butyricum could help improve the immune performance of fattening goats.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.